▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Male and female scientists in lab (2)

Oct 21, 2018 by Keith Speights

Better Buy: GW Pharmaceuticals PLC vs. 22nd Century Group Inc.

Which stock wins in a battle between these two biotechs?

Marijuana leaf on top of $100 bill

Oct 21, 2018 by Keith Speights

Better Buy: Aurora Cannabis Inc. vs. Canopy Growth Corporation

Which stock wins in a head-to-head matchup between these two top Canadian marijuana growers?

Marijuana growing in greenhouse

Oct 21, 2018 by Keith Speights

Better Marijuana Stock: Cronos Group vs. Supreme Cannabis

Which stock wins in a matchup between these two Canadian marijuana growers?

Time to buy

Oct 21, 2018 by Keith Speights

2 Stocks I Bought While the Market Was Falling -- and Why They're Still Great Buys

These fast-growing stocks are awesome picks regardless of what the market does.

Wall Street sign in front of NYSE

Oct 21, 2018 by Keith Speights

Which Canadian Marijuana Stock Will Enjoy a Bigger Bump From Its NYSE Listing -- Aphria or Aurora?

Both Aphria and Aurora have a lot to gain from trading on the biggest stock exchange in the world.

DNA and world

Oct 21, 2018 by Keith Speights

Better Buy: CRISPR Therapeutics AG vs. Intellia Therapeutics Inc.

Which stock wins in a matchup between these two gene-editing pioneers?

Big bet on craps table

Oct 21, 2018 by Keith Speights

Here's Which Marijuana Stocks Investors Are Betting Against the Most

Hint: Tilray isn't one of them.

Marijuana leaves with shadow of maple leaf

Oct 18, 2018 by Keith Speights

The 1 Thing Investors Should Do Now That Canadian Marijuana Stocks Have Fallen

This might be really hard to do, but it's the best action you can take.

Dart and DNA helix

Oct 18, 2018 by Keith Speights

Is Sangamo Therapeutics Inc. a Buy?

Can this beaten-down gene-editing and gene therapy biotech bounce back?

Businessman looking at falling line chart

Oct 17, 2018 by Keith Speights

Why Youngevity International Inc. Is Tanking Today

The multilevel marketer appears to be getting pulled down by declines for other cannabis stocks.

Marijuana leaves with shadow of dollar sign

Oct 17, 2018 by Keith Speights

Just How Big Will the Marijuana Market Really Be?

Marijuana will be big. But don't get carried away by all the hype.

Legal marijuna signs

Oct 17, 2018 by Keith Speights

Is "the Apple Store of Weed" a Buy After the Biggest Marijuana Acquisition in U.S. History?

MedMen makes a huge deal that gives it a huge opportunity.

Marijuana plants on stacks of coins

Oct 17, 2018 by Keith Speights

Sizing Up the 5 Biggest Canadian Marijuana Stocks as the Country's Recreational Market Opens

Here are the biggest players in the cannabis industry on Canada's big day.

Marijuana buds, cigarettes, and Canadian maple leaf

Oct 16, 2018 by Keith Speights

What to Expect With Canadian Marijuana Stocks This Week

Canada's recreational marijuana market opens on Wednesday. Are marijuana stocks likely to soar -- or sink?

Marijuana leaves surrounding red Canadian maple leaf

Oct 15, 2018 by Keith Speights

Why Marijuana Stocks Canopy Growth, Cronos Group, and Tilray Crushed It Today

Excitement is mounting for the opening of Canada's recreational marijuana market on Wednesday.

Pills on top of US map

Oct 15, 2018 by Keith Speights

Why AcelRx Pharmaceuticals Inc. Is Jumping Today

A positive recommendation from an FDA advisory committee generates excitement among investors about this small biotech.

Marijuana leaf and caduceus in cart on top of money

Oct 15, 2018 by Keith Speights

3 Marijuana Stocks to Buy in October

Two big players in the cannabis industry and one up-and-comer look like great picks.

Marijuana close-up in greenhouse

Oct 14, 2018 by Keith Speights

Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

Is bigger better in a battle between these two Canadian marijuana stocks?

Two marijuana leaves

Oct 14, 2018 by Keith Speights

Is This High-Flying Marijuana Stock the Next Tilray?

The similarities are striking.

Marijuana leaf in drink

Oct 14, 2018 by Keith Speights

Better Buy: Aphria Inc. vs. Constellation Brands, Inc.

It's cannabis going up against Corona (with some cannabis thrown into the mix) in the battle between these two stocks.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services